Valeant soars on plan to buy Salix for $10 billion By: MarketWatch February 23, 2015 at 11:03 AM EST Shares of Valeant soared Monday on its plan to buy Salix Pharmaceuticals for $158 a share, or $10 billion. Read More >> Related Stocks: Actavis Plc Valeant Pharmaceuticals International, Inc.